NeuroPace Analyst Price Targets - Benzinga

NeuroPace Inc

NPCENASDAQ

Trade with Public

Trade with Public

$13.08

0.171.32%

Ult. Agg.: Oct 26, 11:49 AM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

NeuroPace Analyst Price Targets

Wall Street analyst price targets and consensus rating for NeuroPace (NPCE).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingOverweight# Analysts9Avg. Consensus PT$18Upside to Avg. PT+35.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 18, 2026	Keybanc	Brett Fishbin	Initiate	Overweight	$18
Jul 29, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$20
Jul 23, 2026	Mizuho	Anthony Petrone	Initiate	Outperform	$22
May 15, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$19→$20
Jan 27, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$18→$19
Dec 16, 2025	UBS	Priya Sachdeva	PT Raise	Buy	$18→$22
Dec 10, 2025	JP Morgan	Rohin Patel	PT Raise	Overweight	$18→$20
Nov 5, 2025	JP Morgan	Rohin Patel	PT Raise	Overweight	$16→$18
Nov 5, 2025	Wells Fargo	Vik Chopra	PT Raise	Overweight	$15→$16
Aug 13, 2025	Wells Fargo	Vik Chopra	PT Cut	Overweight	$17→$15
May 28, 2025	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$18
May 14, 2025	JP Morgan	Robbie Marcus	PT Raise	Overweight	$14→$16
May 14, 2025	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$17
Apr 14, 2025	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$20→$17
Mar 5, 2025	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$19→$20
Jan 30, 2025	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$13→$17
Jan 21, 2025	UBS	Priya Sachdeva	Initiate	Buy	$17
Dec 17, 2024	JP Morgan	Robbie Marcus	PT Raise	Overweight	$9→$14
Nov 13, 2024	Wells Fargo	Vik Chopra	PT Cut	Overweight	$15→$13
Aug 14, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$18

Analyst Ratings News

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Avi Kapoor

PRO
Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18

Keybanc analyst Brett Fishbin initiates coverage on NeuroPace (NASDAQ:NPCE) with a Overweight rating and announces Price Target of $18.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on NeuroPace, Maintains $20 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates NeuroPace (NASDAQ:NPCE) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
Mizuho Initiates Coverage On NeuroPace with Outperform Rating, Announces Price Target of $22

Mizuho analyst Anthony Petrone initiates coverage on NeuroPace (NASDAQ:NPCE) with a Outperform rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on NeuroPace, Raises Price Target to $20

HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and raises the price target from $19 to $20.

Benzinga Newsdesk

Beyond The Numbers: 5 Analysts Discuss NeuroPace Stock

Benzinga Insights